Gene therapy for mitochondrial disease by delivering restriction endonucleaseSmaI into mitochondria
Journal of Biomedical Science2002Vol. 9(6), pp. 534–541
Citations Over Time
Masashi Tanaka, Harm-Jan Borgeld, Jin Zhang, Shin‐ichi Muramatsu, Jian‐Sheng Gong, Makoto Yoneda, Wakako Maruyama, Makoto Naoi, Tohru Ibi, Ko Sahashi, Masayo Shamoto, Noriyuki Fuku, Miyuki Kurata, Yoshiji Yamada, Kumi Nishizawa, Yukihiro Akao, Nobuko Ohishi, Shigeaki Miyabayashi, Hiraku Umemoto, Tatsuo Muramatsu, Koichi Furukawa, Akihiko Kikuchi, Imaharu Nakano, Keiya Ozawa, Kunio Yagi
Related Papers
- → Concise Review: Heteroplasmic Mitochondrial DNA Mutations and Mitochondrial Diseases: Toward iPSC-Based Disease Modeling, Drug Discovery, and Regenerative Therapeutics(2016)33 cited
- → Recent developments in the molecular genetics of mitochondrial disorders(1998)80 cited
- → Mitochondrial genome and human mitochondrial diseases(2010)22 cited
- → Heteroplasmy Shifting as Therapy for Mitochondrial Disorders(2019)16 cited
- → Genome editing to treat mitochondrial DNA disorders(2015)